Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Clinical trial NCT05630976 · COMPLETED

Trial details

NCT number: NCT05630976
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Invasive Fungal Disease

Start date: 2023-02-07
Primary completion: 2025-04-11
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.